Close Menu

Bruce Compton has become vice president and general manager for the chromatography business unit of Eksigent Technologies, the company said this week. He joins Livermore, Calif.-based Eksigent from Thermo Electron, where he was vice president and general manager for chromatography products. Prior to that, he was director of research and development for the chemical division, and later vice president of advanced separation technology, of Waters.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.